Literature DB >> 9223506

Transcription factor binding sites downstream of the human immunodeficiency virus type 1 transcription start site are important for virus infectivity.

C Van Lint1, C A Amella, S Emiliani, M John, T Jie, E Verdin.   

Abstract

When transcriptionally active, the human immunodeficiency virus (HIV) promoter contains a nucleosome-free region encompassing both the promoter/enhancer region and a large region (255 nucleotides [nt]) downstream of the transcription start site. We have previously identified new binding sites for transcription factors downstream of the transcription start site (nt 465 to 720): three AP-1 sites (I, II, and III), an AP3-like motif (AP3-L), a downstream binding factor (DBF) site, and juxtaposed Sp1 sites. Here, we show that the DBF site is an interferon-responsive factor (IRF) binding site and that the AP3-L motif binds the T-cell-specific factor NF-AT. Mutations that abolish the binding of each factor to its cognate site are introduced in an infectious HIV-1 molecular clone to study their effect on HIV-1 transcription and replication. Individual mutation of the DBF or AP3-L site as well as the double mutation AP-1(III)/AP3-L did not affect HIV-1 replication compared to that of the wild-type virus. In contrast, proviruses carrying mutations in the Sp1 sites were totally defective in terms of replication. Virus production occurred with slightly delayed kinetics for viruses containing combined mutations in the AP-1(III), AP3-L, and DBF sites and in the AP3-L and DBF-sites, whereas viruses mutated in the AP-1(I,II,III) and AP3-L sites and in the AP-1(I,II,III), AP3-L, and DBF sites exhibited a severely defective replicative phenotype. No RNA-packaging defect could be measured for any of the mutant viruses as determined by quantification of their HIV genomic RNA. Measurement of the transcriptional activity of the HIV-1 promoter after transient transfection of the HIV-1 provirus DNA or of long terminal repeat-luciferase constructs showed a positive correlation between the transcriptional and the replication defects for most mutants.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9223506      PMCID: PMC191872     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  80 in total

1.  Immune hyperactivation of HIV-1-infected T cells mediated by Tat and the CD28 pathway.

Authors:  M Ott; S Emiliani; C Van Lint; G Herbein; J Lovett; N Chirmule; T McCloskey; S Pahwa; E Verdin
Journal:  Science       Date:  1997-03-07       Impact factor: 47.728

2.  The SV40 enhancer is composed of multiple functional elements that can compensate for one another.

Authors:  W Herr; J Clarke
Journal:  Cell       Date:  1986-05-09       Impact factor: 41.582

3.  Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone.

Authors:  A Adachi; H E Gendelman; S Koenig; T Folks; R Willey; A Rabson; M A Martin
Journal:  J Virol       Date:  1986-08       Impact factor: 5.103

4.  Activation of the AIDS retrovirus promoter by the cellular transcription factor, Sp1.

Authors:  K A Jones; J T Kadonaga; P A Luciw; R Tjian
Journal:  Science       Date:  1986-05-09       Impact factor: 47.728

5.  Human immunodeficiency virus type 1 RNA outside the primary encapsidation and dimer linkage region affects RNA dimer stability in vivo.

Authors:  J I Sakuragi; A T Panganiban
Journal:  J Virol       Date:  1997-04       Impact factor: 5.103

6.  Mutations in both the U5 region and the primer-binding site influence the selection of the tRNA used for the initiation of HIV-1 reverse transcription.

Authors:  S M Kang; J K Wakefield; C D Morrow
Journal:  Virology       Date:  1996-08-15       Impact factor: 3.616

7.  cis-acting sequences located downstream of the human immunodeficiency virus type 1 promoter affect its chromatin structure and transcriptional activity.

Authors:  A el Kharroubi; M A Martin
Journal:  Mol Cell Biol       Date:  1996-06       Impact factor: 4.272

8.  Protein-DNA interactions within DNase I-hypersensitive sites located downstream of the HIV-1 promoter.

Authors:  A el Kharroubi; E Verdin
Journal:  J Biol Chem       Date:  1994-08-05       Impact factor: 5.157

9.  Multiple sequence motifs are involved in SV40 enhancer function.

Authors:  M Zenke; T Grundström; H Matthes; M Wintzerith; C Schatz; A Wildeman; P Chambon
Journal:  EMBO J       Date:  1986-02       Impact factor: 11.598

10.  Mechanisms of transactivation by nuclear factor of activated T cells-1.

Authors:  C Luo; E Burgeon; A Rao
Journal:  J Exp Med       Date:  1996-07-01       Impact factor: 14.307

View more
  60 in total

Review 1.  A compilation of cellular transcription factor interactions with the HIV-1 LTR promoter.

Authors:  L A Pereira; K Bentley; A Peeters; M J Churchill; N J Deacon
Journal:  Nucleic Acids Res       Date:  2000-02-01       Impact factor: 16.971

2.  Stabilization of the U5-leader stem in the HIV-1 RNA genome affects initiation and elongation of reverse transcription.

Authors:  N Beerens; F Groot; B Berkhout
Journal:  Nucleic Acids Res       Date:  2000-11-01       Impact factor: 16.971

3.  Expression of MHC class II in T cells is associated with increased HIV-1 expression.

Authors:  M Saifuddin; G T Spear; C Chang; K A Roebuck
Journal:  Clin Exp Immunol       Date:  2000-08       Impact factor: 4.330

4.  Kinase control prevents HIV-1 reactivation in spite of high levels of induced NF-κB activity.

Authors:  Frank Wolschendorf; Alberto Bosque; Takao Shishido; Alexandra Duverger; Jennifer Jones; Vicente Planelles; Olaf Kutsch
Journal:  J Virol       Date:  2012-02-15       Impact factor: 5.103

Review 5.  Regulation of HIV-1 transcription.

Authors:  K A Roebuck; M Saifuddin
Journal:  Gene Expr       Date:  1999

6.  Cell cycle arrest in G2 induces human immunodeficiency virus type 1 transcriptional activation through histone acetylation and recruitment of CBP, NF-kappaB, and c-Jun to the long terminal repeat promoter.

Authors:  Sylvain Thierry; Vincent Marechal; Michelle Rosenzwajg; Michèle Sabbah; Gérard Redeuilh; Jean-Claude Nicolas; Joël Gozlan
Journal:  J Virol       Date:  2004-11       Impact factor: 5.103

7.  Genetic analysis of the long terminal repeat (LTR) promoter region in HIV-1-infected individuals with different rates of disease progression.

Authors:  Eva Ramírez de Arellano; Cristina Martín; Vincent Soriano; José Alcamí; Africa Holguín
Journal:  Virus Genes       Date:  2006-12-09       Impact factor: 2.332

8.  Recruitment of chromatin-modifying enzymes by CTIP2 promotes HIV-1 transcriptional silencing.

Authors:  Céline Marban; Stella Suzanne; Franck Dequiedt; Stéphane de Walque; Laetitia Redel; Carine Van Lint; Dominique Aunis; Olivier Rohr
Journal:  EMBO J       Date:  2007-01-24       Impact factor: 11.598

9.  Optimal translation initiation enables Vif-deficient human immunodeficiency virus type 1 to escape restriction by APOBEC3G.

Authors:  Guylaine Haché; Truus E M Abbink; Ben Berkhout; Reuben S Harris
Journal:  J Virol       Date:  2009-03-18       Impact factor: 5.103

10.  An interferon regulatory factor binding site in the U5 region of the bovine leukemia virus long terminal repeat stimulates Tax-independent gene expression.

Authors:  V Kiermer; C Van Lint; D Briclet; C Vanhulle; R Kettmann; E Verdin; A Burny; L Droogmans
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.